Payments to Acquire Property, Plant, and Equipment of IOVANCE BIOTHERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
IOVANCE BIOTHERAPEUTICS, INC. annual and quarterly Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • IOVANCE BIOTHERAPEUTICS, INC. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $6,211,000, a 49% increase year-over-year.
  • IOVANCE BIOTHERAPEUTICS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2025 was $33,836,000, a 206% increase from 2024.
  • IOVANCE BIOTHERAPEUTICS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $11,069,000, a 50% decline from 2023.
  • IOVANCE BIOTHERAPEUTICS, INC. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $22,290,000, a 9.1% increase from 2022.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)

IOVANCE BIOTHERAPEUTICS, INC. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $33,836,000 +$22,767,000 +206% 01 Jan 2025 31 Dec 2025 10-K 24 Feb 2026 2025 FY
2024 $11,069,000 -$11,221,000 -50% 01 Jan 2024 31 Dec 2024 10-K 24 Feb 2026 2025 FY
2023 $22,290,000 +$1,865,000 +9.1% 01 Jan 2023 31 Dec 2023 10-K 24 Feb 2026 2025 FY
2022 $20,425,000 -$17,149,000 -46% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2025 2024 FY
2021 $37,574,000 -$9,217,000 -20% 01 Jan 2021 31 Dec 2021 10-K 28 Feb 2024 2023 FY
2020 $46,791,000 +$39,874,000 +576% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2023 2022 FY
2019 $6,917,000 +$5,719,000 +477% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $1,198,000 +$170,000 +17% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $1,028,000 -$493,000 -32% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $1,521,000 +$378,000 +33% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $1,143,000 -$449,000 -28% 01 Jan 2015 31 Dec 2015 10-K 12 Mar 2018 2017 FY
2014 $1,592,000 +$1,579,000 +12146% 01 Jan 2014 31 Dec 2014 10-K 09 Mar 2017 2016 FY
2013 $13,000 +$13,000 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016 2015 FY
2012 $0 -$31,053 -100% 01 Jan 2012 31 Dec 2012 10-K 28 Mar 2014 2013 FY
2011 $31,053 +$31,053 01 Jan 2011 31 Dec 2011 10-K 23 Sep 2013 2012 FY
2010 $0 01 Jan 2010 31 Dec 2010 10-K 30 Mar 2012 2011 FY

IOVANCE BIOTHERAPEUTICS, INC. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $6,211,000 +$2,040,000 +49% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $4,171,000 -$1,493,000 -26% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $5,664,000 -$5,776,000 -50% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q1 2022 $11,440,000 +$735,000 +6.9% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023 2023 Q1
Q1 2021 $10,705,000 +$10,068,000 +1581% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $637,000 -$187,000 -23% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $824,000 +$802,000 +3645% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
Q1 2018 $22,000 -$776,000 -97% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $798,000 +$796,000 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $2,000* -$780,000 01 Jan 2016 31 Mar 2016 10-Q 03 May 2017 2017 Q1
Q1 2015 $782,000 +$778,563 +22652% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q1 2014 $3,437 +$3,437 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q1 2013 $0 $0 01 Jan 2013 31 Mar 2013 10-Q 23 Oct 2013 2013 Q1
Q1 2012 $0 $0 01 Jan 2012 31 Mar 2012 10-Q 23 Oct 2013 2013 Q1
Q1 2011 $0 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012 2012 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.